Biotest Pharmaceuticals Announces First Commercial Sales of BIVIGAM™
2/4/2013 10:30:21 AM
More...
|
Biotest Pharmaceuticals Release: BIVIGAM™ [Immune Globulin Intravenous (Human), 10% Liquid] is the First New IVIG Product Approved With a Validated and FDA Approved Thrombin Generation Assay (TGA) Test
2/1/2013 9:20:02 AM
More...
|
Biotest Pharmaceuticals Signs Supply, License Pact With ADMA Biologics, Inc.
1/11/2013 7:10:51 AM
More...
|
Biotest Pharmaceuticals Announces Jordan Siegel as New Chief Executive Officer
3/9/2012 7:18:12 AM
More...
|
Althea Technologies, Inc. and Biotest Pharmaceuticals Establish Commercial Filling Agreement
5/3/2011 8:35:00 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Withdrawal of Biotest Pharmaceuticals's Indemnification Claim
11/4/2009 8:40:15 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Withdrawal of Biotest Pharmaceuticals's Indemnification Claim
6/1/2009 9:29:40 AM
More...
|
Biotest Pharmaceuticals Acquires Santa Fe, New Mexico Plasmapheresis Center
2/11/2009 11:26:49 AM
More...
|
Biotest Pharmaceuticals Responds to Orphan Drug Act Announcement
3/27/2008 8:29:25 AM
More...
|